glp-1 news 2025 october 21 Consumers' Expectations about Drugs Economic Impact on Food System Players GLP-1 Agonists Market Report 2025-2033,

Description

The industry is expected to grow at a CAGR of 10.1% from 2025 to 2035

Tirzepatide's powerful gastric emptying effects combined with cagrilintide's even stronger gastric slowing could create severe GI complications

[4] And if you want to avoid pregnancy, its vital to understand how the treatment interacts with oral contraceptives and birth control to stay protected

Lancet 330(8571):13001304 [Google Scholar] Kushner RF, Calanna S, Davies M, Dicker D, Garvey WT, Goldman B et al (2020) Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5

Typical 12-month results include 10 to 15% body weight loss (20 to 35 pounds for a 200-pound person), 2 to 4 inch waist circumference reduction, noticeable improvement in body composition especially with exercise, and significant improvement in metabolic markers if they were elevated